Literature DB >> 12881356

Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet's disease.

Y Chen, M R Stanford, G R Wallace, R W Vaughan, E Kondeatis, F Fortune.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12881356      PMCID： PMC1771783          DOI： 10.1136/bjo.87.8.1048

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  8 in total

1.  Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

Authors:  E Gonzalez; R Dhanda; M Bamshad; S Mummidi; R Geevarghese; G Catano; S A Anderson; E A Walter; K T Stephan; M F Hammer; A Mangano; L Sen; R A Clark; S S Ahuja; M J Dolan; S K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.

Authors:  Gerard Espinosa; Josep Font; Dolors Tàssies; Antonio Vidaller; Ramon Deulofeu; Alfons López-Soto; Ricard Cervera; Antoni Ordinas; Miguel Ingelmo; Joan-Carles Reverter
Journal:  Am J Med       Date:  2002-01       Impact factor: 4.965

3.  Factor V Leiden mutation in patients with Behçet's disease.

Authors:  A F Oner; A Gürgey; A Gürler; L Mesci
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

4.  Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease.

Authors:  A Gül; U Ozbek; C Oztürk; M Inanç; M Koniçe; T Ozçelik
Journal:  Br J Rheumatol       Date:  1996-11

5.  Factor V Leiden mutation is associated with ocular involvement in Behçet disease.

Authors:  D H Verity; R W Vaughan; W Madanat; E Kondeatis; H Zureikat; F Fayyad; C A Kanawati; I Ayesh; M R Stanford; G R Wallace
Journal:  Am J Ophthalmol       Date:  1999-09       Impact factor: 5.258

6.  Resistance to activated protein C as a basis for venous thrombosis.

Authors:  P J Svensson; B Dahlbäck
Journal:  N Engl J Med       Date:  1994-02-24       Impact factor: 91.245

7.  The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.

Authors:  I Martinelli; P Bucciarelli; M Margaglione; V De Stefano; G Castaman; P M Mannucci
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

8.  Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.

Authors:  I Martinelli; P M Mannucci; V De Stefano; E Taioli; V Rossi; F Crosti; K Paciaroni; G Leone; E M Faioni
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113
  8 in total
  1 in total

1.  Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.